Skip to main content

Table 3 Contents and results of radiotherapy (with or without chemotherapy) for postoperative recurrent esophageal cancer. in previous studies. The numbers in parenthesis are a numbers of patients.

From: Results of radiation therapy combined with nedaplatin (cis-diammine-glycoplatinum) and 5-Fluorouracil for postoperative locoregional recurrent esophageal cancer

author year No. regimen response rate median survival time 1-year survuval rate
JL Raoul [13] 1995 24 radiotherapy + chemotherapy 65% - 47.1%
H Yamanaka [25] 1998 17 radiotherapy + CDGP§ + 5-FU# 76.50% - -
K Nemoto [15] 2001 33 radiotherapy alone(21) or radiotherapy + CDDP* + 5-FU (12) - 7 months 33%
Y Nishimura [12] 2003 13 radiotherapy + CDDP + 5-FU 72% 9.5 months 28%
H Shimada [14] 2003 76 chemoradiotheray(47), chemotherapy alone(17), radiotherapy alone(12) 34% 8 months 31%
K Nemoto [16] 2003 7 radiotherapy + CDGP + 5-FU 100% - 69%
  1. * CDDP: cisplatin, § CDGP: nedaplatin, # 5-FU: 5-fluorouracil
\